Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients

Fig. 2

Graph illustrating changes in the amount of decrease in best-corrected visual acuity (BCVA) and central subfield retinal thickness (CST). Both type 1 MNV (A) and type 2 MNV (B) groups show significant improvement in the BCVA and CST after 2 years, regardless of the presence of persistent SRF. The BCVA and CST changes from baseline with the relaxed treat-and-extend regimen did not differ in the persistent SRF (+) and persistent SRF (−) groups for both type 1 and type 2 MNV during the 2-year follow-up

Back to article page